As the Gudi Padwa festival approaches, Kalyan Jewellers has launched a vibrant campaign featuring brand ambassador Pooja Sawant. This initiative aims to celebrate the evolving bonds within families during this auspicious time, which is particularly significant for Maharashtrians, marking a period of prosperity and renewal.

On March 19, 2026, the campaign was unveiled, coinciding with a challenging phase for the company in the stock market. Despite a remarkable annual net sales growth rate of 32.82% and an operating profit growth rate of 38.87%, Kalyan Jewellers’ stock has faced a decline of 22.06% year-to-date, with an 11.40% drop over the past year.

These financial metrics are noteworthy, especially considering that Kalyan Jewellers has reported positive results for 11 consecutive quarters. The latest quarter saw a profit before tax of ₹537.26 crores, reflecting a significant increase of 101.1% compared to the previous four-quarter average.

However, the recent drop in gold prices has affected major players in the jewellery sector, including Kalyan Jewellers. This decline in gold prices could pose challenges for the company as it navigates its market strategy amidst fluctuating commodity values.

In addition to its campaign, Kalyan Jewellers emphasizes its commitment to customer satisfaction through initiatives like the 4-Level Assurance Certificate for purity certification, free lifetime maintenance, and transparent buy-back policies. These offerings are designed to build trust and loyalty among customers, particularly during festive seasons when jewellery purchases typically surge.

Despite the stock market challenges, analysts have noted that Kalyan Jewellers has a PEG ratio of 0.5, indicating potential undervaluation relative to its earnings growth. This could suggest that the company may be positioned for a rebound, provided it can effectively manage the current market conditions.

As of February 6, 2026, Kalyan Jewellers was rated ‘Hold’ by MarketsMOJO, reflecting a cautious optimism about its future performance. The juxtaposition of a robust sales growth against the backdrop of stock decline presents a complex picture for investors and stakeholders.

The ongoing Gudi Padwa campaign not only aims to enhance brand visibility but also serves as a reminder of the cultural significance of the festival. For Kalyan Jewellers, this campaign is a strategic move to reinforce its market presence while addressing the challenges posed by external economic factors.

As the festival unfolds, the performance of Kalyan Jewellers will be closely watched, both for its impact on the company’s financial health and its ability to resonate with consumers during this culturally rich time.

Details remain unconfirmed regarding the long-term effects of the current market conditions on Kalyan Jewellers, but the company’s proactive approach in celebrating Gudi Padwa may provide a much-needed boost.

The post Kalyan Jewellers Launches Gudi Padwa Campaign Amidst Market Challenges appeared first on bangalinews.

A counterfeit drug network was dismantled by Delhi Police on September 1, 2025, involving multiple arrests and significant seizures of illegal substances. The operation revealed connections between suppliers in Uttarakhand and traders in Delhi, with Tanishq Jha’s factory in Patna identified as a key player in the production of counterfeit medicines.

The police laid a trap to catch a courier delivering a package containing Tramadol premix, leading to the arrest of Anirudh Rai. Following this, authorities uncovered a broader network that included Amit, who allegedly stored 20 kilograms of Tramadol premix in his warehouse in Roorkee, and Prashant, who acted as an intermediary linking suppliers to buyers across North India.

In total, the Delhi Police seized counterfeit medicines and psychotropic drugs valued at nearly Rs 50 crore. This operation highlights the extensive nature of the counterfeit drug trade, which has been a growing concern in India.

According to a senior Crime Branch officer, “The goal was to trace the supply chain behind the material.” The investigation revealed a complex web involving suppliers of raw materials, brokers, transporters, and manufacturing units where the raw materials were converted into tablets or syrups.

The pharmaceutical belt around Roorkee has seen the emergence of many small manufacturers since Uttarakhand was carved out of Uttar Pradesh, leading to increased scrutiny of their operations. A Crime Branch officer noted, “When factories shut down or excess stock remains in the warehouses, middlemen sometimes try to move the material quickly.”

Authorities are continuing to investigate the network, which has raised alarms about the safety of pharmaceutical products in the region. The profits from these operations were reportedly shared between the brokers and the traders who sourced the material.

As the investigation unfolds, further details may emerge regarding the extent of the counterfeit drug operations and the individuals involved. The crackdown on this network is part of a larger effort by law enforcement to combat the growing issue of counterfeit drugs in India.

Details remain unconfirmed regarding the full scope of the network and the potential involvement of additional individuals.

The post Tanishq: Counterfeit Drug Network Involving Jha Busted in Delhi appeared first on bangalinews.